Why the study?
Ischemia–reperfusion injury is a significant contributor to myocardial injury following hypoperfusion, and sevoflurane demonstrates cardioprotective effects against it through a variety of cellular and molecular mechanisms.
Design
Narrative review
Answers are grounded in this paper and cite their sources.
Sevoflurane cardioprotection in ischemia-reperfusion requires clinical validation; leaves open translation of cellular mechanisms to patient outcomes.
Ischemia–reperfusion injury is a significant contributor to myocardial injury following periods of hypoperfusion. Sevoflurane demonstrates a cardioprotective effect against ischemia- reperfusion through a variety of mechanisms. Here, we provide a narrative review of the current literature surrounding sevoflurane’s effects on ischemia–reperfusion, with a focus on cellular and molecular mechanisms. We conclude with a discussion on clinical implications, and directions for future research.
No takes yet. Share an insight, caveat, or question.
Bui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: